Crk family adaptor proteins trans-activate c-Abl kinase

Genes to Cells

Volumn 6, Issue 5, 2001, Pages 431-440

  Shishido, Tomoyuki ^a,b,c   Akagi, Tsuyoshi ^a,b   Chalmers, Alistair ^a   Maeda, Makiko ^a   Terada, Toshie ^a   Georgescu, Maria Magdalena ^b   Hanafusa, Hidesaburo ^a,b  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b ROCKEFELLER UNIVERSITY   (United States)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; PROLINE; PROTEIN TYROSINE KINASE; TRANS ACTING FACTOR; TRANSACTIVATOR PROTEIN; TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOLOGY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MOLECULE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; STIMULUS; TRANSACTIVATION;

ANIMALS; BINDING SITES; CELL LINE, TRANSFORMED; CHICK EMBRYO; FIBROBLASTS; IMMUNOHISTOCHEMISTRY; MICE; MUTATION; ONCOGENE PROTEIN V-CRK; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-CRK; RETROVIRIDAE PROTEINS, ONCOGENIC; SRC HOMOLOGY DOMAINS; TRANS-ACTIVATION (GENETICS); TYROSINE;

EID: 0035018366     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2443.2001.00431.x     Document Type: Article

References (28)

1. Akagi, T., Shishido, T., Murata, K. & Hanafusa, H. (2000) v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc. Natl. Acad. Sci. USA 97, 7290-7295.
2. Barila, D. & Superti-Furga, G. (1998) An intramolecular SH3-domain interaction regulates c-Abl activity. Nature Genet. 18, 280-282.
3. Bishop, J.M. (1985) Viral oncogenes. Cell 42, 23-38.
4. Druker, B.J., Tamura, S., Buchdunger, E., et al. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Med. 2, 561-566.
5. Feller, S.M., Knudsen, B. & Hanafusa, H. (1994) c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13, 2341-2351.
6. Hanafusa, H. (1969) Rapid transformation of cells by Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 63, 318-325.
7. Kizaka-Kondoh, S., Matsuda, M. & Okayama, H. (1996) CrkII signals from epidermal growth factor receptor to Ras. Proc. Natl. Acad. Sci. USA 93, 12177-12182.
8. Lewis, J.M., Baskaran, R., Taagepera, S., Schwartz, M.A. & Wang, J. Y. (1996) Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc. Natl. Acad. Sci. USA 93, 15174-15179.
9. Matsuda, M., Tanaka, S., Nagata, S., Kojima, A., Kurata, T. & Shibuya, M. (1992) Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol. 12, 3482-3489.
10. Mayer, B.J. & Baltimore, D. (1994) Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14, 2883-2894.
11. Mayer, B.J., Hamaguchi, M. & Hanafusa, H. (1988) A novel viral oncogene with structural similarity to phospholipase C. Nature 332, 272-275.
12. Mayer, B.J. & Hanafusa, H. (1990a) Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation. J. Virol. 64, 3581-3589.
13. Mayer, B.J. & Hanafusa, H. (1990b) Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity. Proc. Natl. Acad. Sci. USA 87, 2638-2642.
14. Mayer, B.J., Hirai, H. & Sakai, R. (1995) Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr. Biol. 5, 296-305.
15. Mayer, B.J., Jackson, P.K., Van Etten, R.A. & Baltimore, D. (1992) Point mutations in the ab1 SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol. Cell. Biol. 12, 609-618.
16. McWhirter, J.R. & Wang, J.Y. (1993) An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12, 1533-1546.
17. Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
18. Pendergast, A.M., Muller, A.J., Havlik, M.H., Clark, R., McCormick, F. & Witte, O.N. (1991) Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. Proc. Natl. Acad. Sci. USA 88, 5927-5931.
19. Reichman, C.T., Mayer, B.J., Keshav, S. & Hanafusa, H. (1992) The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ. 3, 451-460.
20. Ren, R., Ye, Z.S. & Baltimore, D. (1994) Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8, 783-795.
21. Rosen, M.K., Yamazaki, T., Gish, G.D., Kay C.M., Pawson, T. & Kay, L.E. (1995) Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 374, 477-479.
22. Sawyers, C.L., McLaughlin, J., Goga, A., Havlik, M. & Witte, O. (1994) The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77, 121-131.
23. Senechal, K., Heaney C., Druker, B. & Sawyers, C.L. (1998) Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells. Mol. Cell. Biol. 18, 5082-5090.
24. Shishido, T., Akagi, T., Ouchi, T., Georgescu, M.M., Langdon, W.Y. & Hanafusa, H. (2000) The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. Proc. Natl. Acad. Sci. USA 97, 6439-6444.
25. Van Etten, R.A., Jackson, P. & Baltimore, D. (1989) The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58, 669-678.
26. Van Etten, R.A., Jackson, P.K., Baltimore, D., Sanders, M.C., Matsudaira, P.T. & Janmey, P.A. (1994) The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124, 325-340.
27. Wang, B., Mysliwiec, T., Feller, S.M., Knudsen, B., Hanafusa, H. & Kruh, G.D. (1996) Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk. Oncogene 13, 1379-1385.
28. Wen, S.T. & Van Etten, R.A. (1997) The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11, 2456-2467.